The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
resulted in the emergence of new variant lineages that have exacerbated the COVID-19 …

Currently available vaccines against severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) are highly effective but not able to keep the coronavirus disease 2019 …

Results Among 1870 patients receiving maintenance dialysis, 1569 had no prior COVID-19.
Patients without prior COVID-19 had declining titers over time. Among 443 recipients of …

Taking into account higher risk of severe coronavirus disease 2019 or death among patients
with cancer, as well as impaired immunogenicity after anti-SARS-CoV-2 vaccines, in …

Objective To provide guidance to rheumatology providers on the use of COVID‐19 vaccines
for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …

Waning vaccine-induced immunity coupled with the emergence of SARS-CoV-2 variants
has led to increases in breakthrough infections, prompting consideration for vaccine booster …

Diagnostic assays currently used to monitor the efficacy of COVID-19 vaccines measure
levels of antibodies to the receptor-binding domain of ancestral SARS-CoV-2 (RBDwt) …

Group 2B β-coronaviruses (sarbecoviruses) have caused regional and global epidemics in
modern history. Here, we evaluate the mechanisms of cross-sarbecovirus protective …

Understanding vaccine-mediated protection against severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) is critical to overcoming the global coronavirus disease 2019 …

The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has resulted in the generation of variants that may diminish host immune responses to …